• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Issues that matter
    • COVID-19 in India
    • Inadequate safe drinking water
    • Poor sanitation
    • Environmental health
    • Infectious disease
      • Hepatitis C
    • Noncommunicable Diseases (NCDs)
    • Malnutrition
    • High infant mortality
    • Mental health
    • Sex and gender discrimination
  • Special Focus
    • Interviews
      • Exclusive Interviews
      • Readers Interviews
    • Vaccine Hesitancy
  • News
  • PandemiCast
  • Partner’s Press Office

Health Issues India

Health issues in India

  • Home
  • About Us
  • Editorial Team
  • Subscribe
  • Contribute
  • Sponsor
  • Contact Us
You are here: Home / Featured / India’s patent system on meds may be the new normal #accesstomedicine #patent

India’s patent system on meds may be the new normal #accesstomedicine #patent

September 16, 2013 By Mark Chataway Leave a Comment

Share

There has been a lot of wailing amongst multinational pharma companies about India’s uniquely unfriendly attitude to patents. Now, it might be starting to look like the new normal.

The MNC’s are worried about three separate developments in India that they think will reduce incentives for innovation

  • Compulsory licences where a local manufacturer is allowed to produce a low-cost version of a patented medicine that the government considers to be priced unreasonably. This may be allowed under a provision of the international agreement governing intellectual property rights (the TRIPS agreement) although the MNCs argue that this provision should only be used in unforeseen public health emergencies. India has only actually issued one CL although another is in the system. As Tapan Ray points out in a recent blog post, this is a much less aggressive attitude than has been taken in other fast growing economies such as Indonesia and Thailand (this piece is not entirely clear about the various different IP issues but remarkable because it comes from the Director General of the Organization of Pharmaceutical Producers of India, a group which represents multinational pharma)
  • Declaring patents to be invalid because they do not represent a real discovery. India’s courts recently did this to cancer drugs from Novartis and Roche (although in Roche’s case, the MNC case was weakened because the company had forgotten to file its patent renewal documents on time and depended on officials to allow it extra time). China has just used identical reasoning to declare that Gilead’s patent on tenofovir to be invalid. (We reported last year that Gilead was probably one of the major objectives of a new Chinese law permitting CLs). Tapan Ray also claims that the EU has done the same to Roche. 
  • Not enforcing patent law. MSD / Merck & Co ran across this problem when state authorities in Sikkim licensed Glenmark Pharmaceuticals to produce a generic version of its diabetes drug Januvia (sitagliptin, Merck). No-one had suggested until that point that there was any problem with the Januvia patent in India (although some have suggested it since) . Merck’s application to stop Glenmark is wending its way through India’s complicated and often slow legal system and, in the meantime, Glenmark is selling. This problem is worse in most fast growing economies. As the US Patent and Trademark Office noted in a recent report this shouldn’t happen but, “the [Chinese] system has significant shortcomings that diminish if not eliminate its efficacy.”

The US government has shown itself to be unwilling or unable to shift India’s position significantly despite what five ex-US ambassadors to India called, “aggressive lobbying by US firms against India on business issues that has jeopardised bilateral ties lately.” (They were writing to President Obama, mostly about immigration but on a range of trade issues). There has been a vigorous exchange between some US lawmakers and the Indian ambassador to the US. India, though, is not giving in and the US doesn’t seem willing to offer a big enough political tit for tat.

 

14545628_m

Image credit: <a href=’http://www.123rf.com/photo_14545628_pharmacy-chemist-woman-in-drugstore.html’>kadmy / 123RF Stock Photo</a>

Filed Under: Featured

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Articles

  • US declares monkeypox a public health emergency; The latest health stories from around the world
  • First Asian monkeypox death occurs in India
  • President Joe Biden tests positive for COVID-19 a second time; The latest health stories from around the world
  • Monkeypox officially declared a global emergency by WHO; The latest health stories from around the world
  • Four monkeypox cases now reported in India

Footer

Archives

Issues that matter

  • Environmental health
  • Inadequate safe drinking water
  • Poor sanitation
  • Infectious disease
  • Noncommunicable Diseases (NCDs)
  • Malnutrition
  • High infant mortality

Categories

Copyright © 2022 · News Pro On Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
Cookie settingsACCEPTACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.